Premeeting Workshop:
PW7. Hepatitis C Premeeting Workshop ($)
Wednesday, October 7, 2015: 8:00 AM-12:00 PM
Room: San Diego Convention Center, 7--AB
IDSA Clinical Affairs Committee and Hepatitis Task Force

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe updated treatment guidelines
  • list new non-invasive modalities for assessment of liver damage and genetic markers
  • identify the latest drugs approved for HCV mono-infection and HCV-HIV co-infection
  • describe strategies to optimize patient and provider services
  • discuss medical problems common to HCV patients and the basics of care of the compensated cirrhotic patient

Target Audience: Members-in-training, Infectious diseases physicians, HIV clinicians, Fellows, Clinicians

Tracks: Adult ID, HIV-STD-TB

Pre-Meeting Workshop Moderators:  Eliot Godofsky, MD, FIDSA, Bach and Godofsky and David Thomas, MD, MPH, FIDSA, Johns Hopkins University School of Medicine

CME Credits: Maximum of 4 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 4.0 knowledge-based contact hours (0.4 CEU) of pharmacy CE

ACPE Number: 0221-9999-15-142-L01-P

Disclosures:

E. Godofsky, AbbVie: Consultant and Investigator , Consulting fee and Research support
Janssen: Consultant and Investigator , Consulting fee and Research support
Gilead: Investigator , Research support
Vertex: Investigator , Research support
Novartis: Investigator , Research support
Merck: Investigator , Research support
Boeringer-Ingelheim: Investigator , Research support
Anadys: Investigator , Research support

D. Thomas, None

See more of: Premeeting Workshop

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.